Publication: 2502

Publication: 2502

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from Cancer and Leukemia Group B 9480.

PubMed

DOI

Google Scholar

Citation:: Clin Cancer Res vol 11 (5) 1815-20

Year:: 2005
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:
Grants:: CA 31946

Corr. Author:
Authors:: Daniel J George Susan Halabi Timothy F Shepard Ben Sanford Nicholas J Vogelzang Eric J Small Philip W Kantoff

Networks:

Study: INT-0159
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Adenocarcinoma, Aged, Antineoplastic Agents, Hormonal, Cohort Studies, Drug Resistance, Neoplasm, Humans, Interleukin-6, Male, Middle Aged, Multivariate Analysis, Neoplasm Metastasis, Prognosis, Prostate-Specific Antigen, Prostatic Neoplasms, Survival Analysis